Xponential Fitness Inc is a franchisor of boutique health and wellness brands... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NFRA | 62.99 | 0.37 | +0.59% |
| Northern Trust STOXX Global Broad Infrastructure ETF (NFRA) | |||
| EFFI | 25.80 | N/A | N/A |
| Harbor Osmosis International Resource Efficient ETF | |||
| ABFL | 81.48 | -0.51 | -0.62% |
| Abacus FCF Leaders ETF (ABFL) | |||
| FLDZ | 26.70 | -0.25 | -0.92% |
| TrueShares Patriot Defense ETF (FLDZ) | |||
| BBC | 43.06 | -1.09 | -2.46% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
A.I.dvisor tells us that XPOF and JOUT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XPOF and JOUT's prices will move in lockstep.
| Ticker / NAME | Correlation To XPOF | 1D Price Change % | ||
|---|---|---|---|---|
| XPOF | 100% | -0.20% | ||
| JOUT - XPOF | 28% Poorly correlated | -2.97% | ||
| FNKO - XPOF | 27% Poorly correlated | -0.92% | ||
| YETI - XPOF | 27% Poorly correlated | +0.48% | ||
| ESCA - XPOF | 23% Poorly correlated | -0.75% | ||
| AOUT - XPOF | 22% Poorly correlated | +1.23% | ||
More | ||||
Industry RecreationalProducts
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XPOF declined for three days, in 241 of 284 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
XPOF broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for XPOF entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XPOF's RSI Indicator exited the oversold zone, 34 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on XPOF as a result. In 66 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for XPOF just turned positive on September 25, 2026. Looking at past instances where XPOF's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
XPOF moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where XPOF advanced for three days, in 233 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. XPOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XPOF's P/B Ratio (434.783) is very high in comparison to the industry average of (22.179). P/E Ratio (26.609) is within average values for comparable stocks, (43.087). XPOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.411). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (0.489) is also within normal values, averaging (4.604).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XPOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.